期刊： HIV CLINICAL TRIALS, 2018; 19 (1)
Background: We aimed at investigating the antiviral activity and the pharmacokinetics of the dual antiretroviral (ARV) combination of rilpivirine plus......
期刊： HIV CLINICAL TRIALS, 2018; 19 (1)
Background: Data on the efficacy, safety, and concomitant use with other drugs of the combination ritonavir-boosted paritaprevir/ombitasvir plus dasab......
期刊： HIV CLINICAL TRIALS, 2018; 19 (1)
Background: Research studies rely on accurate assessment of entry criteria in order to maintain study integrity and participant safety, however, chall......
期刊： HIV CLINICAL TRIALS, 2018; 19 (1)
Background: Safety data on pregnancy and fetal outcomes among women in HIV prevention trials are urgently needed to inform use of effective antiretrov......
期刊： HIV CLINICAL TRIALS, 2018; 19 (1)
Objectives: Interactions between antiretroviral treatment (ART) and comedications are a concern in HIV-infected patients. This study aimed to determin......
期刊： HIV CLINICAL TRIALS, 2018; 19 (3)
Background:Hyperlipidaemia is a risk factor for the progression of chronic kidney disease (CKD), which is a frequent comorbidity in patients with HIV-......
期刊： HIV CLINICAL TRIALS, 2018; 19 (3)
Background: Although HIV therapy is delivered to millions globally, treatment default (especially soon after entering care) remains a challenge. Commu......
期刊： HIV CLINICAL TRIALS, 2018; 19 (3)
Background: Russia continues to have an uncontrolled HIV epidemic and its per capita alcohol consumption is among the highest in the world. Alcohol us......
期刊： HIV CLINICAL TRIALS, 2018; 19 (3)
Background: Late-presenting pregnant women pose a challenge in the prevention of HIV-1 mother-to-child-transmission. We compared the safety and effica......
期刊： HIV CLINICAL TRIALS, 2018; 19 (3)
Background: PRO 140 is a humanized monoclonal antibody targeting CCR5 with potent antiviral activity in patients with CCR5-tropic HIV-1 infection. In ......
期刊： HIV CLINICAL TRIALS, 2018; 19 (2)
Objective: Lipid management is one of the cornerstones of cardiovascular risk reduction. Treatment of HIV infection with protease inhibitors (PIs) may......
期刊： HIV CLINICAL TRIALS, 2018; 19 (2)
Background: The number of HIV/AIDS cases in Turkey is increasing rapidly, as is the number of cases worldwide. The aim of this study is to evaluate th......
期刊： HIV CLINICAL TRIALS, 2018; 19 (2)
Background: Viral load measurement is commonly applicable to monitor HIV infection in patients to determine the number of HIV-RNA in serum samples of ......
期刊： HIV CLINICAL TRIALS, 2018; 19 (2)
Background: We aimed to mimic the ACTG 5257 trial, comparing raltegravir (RAL), ritonavir-boosted atazavavir (ATV/r) and ritonavir-boosted darunavir (......
期刊： HIV CLINICAL TRIALS, 2018; 19 (2)
Background: The epidemic of acute HCV infection among HIV-infected men who have sex with men (MSM) is ongoing. Transmission of drug-resistant variants......
